Earnings Preview For Capricor Therapeutics
Earnings Preview For Capricor Therapeutics
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Capricor Therapeutics (NASDAQ:CAPR) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
capricor therapeutics（納斯達克：CAPR）正準備在2024年11月13日星期三公佈季度業績。在發佈之前，這裏是投資者應該了解的內容概覽。
Analysts are estimating that Capricor Therapeutics will report an earnings per share (EPS) of $-0.36.
分析師預計Capricor Therapeutics的每股收益（EPS）爲-0.36美元。
Investors in Capricor Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
Capricor Therapeutics的投資者們正急切地期待公司的公告，希望能夠聽到超過預期的消息，並對下個季度做出積極引導。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投資者注意的是，股票價格往往受未來預期的影響，而不僅僅是過去的業績。
Historical Earnings Performance
歷史業績表現
During the last quarter, the company reported an EPS beat by $0.01, leading to a 8.99% increase in the share price on the subsequent day.
在上一個季度，該公司報告每股收益超出0.01美元，導致隨後一天股價上漲了8.99%。
Here's a look at Capricor Therapeutics's past performance and the resulting price change:
這是Capricor Therapeutics過去表現和隨之而來的價格變化。
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.11 | -0.09 | -0.29 |
| EPS Actual | -0.35 | -0.31 | -0.02 | -0.25 |
| Price Change % | 9.0% | -4.0% | 9.0% | 7.000000000000001% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.36 | -0.11 | -0.09 | -0.29 |
| 每股收益實際值 | -0.35 | -0.31 | -0.02 | -0.25 |
| 價格變更% | 9.0% | -4.0% | 9.0% | 7.000000000000001% |
Performance of Capricor Therapeutics Shares
Capricor Therapeutics股價表現
Shares of Capricor Therapeutics were trading at $19.54 as of November 11. Over the last 52-week period, shares are up 508.72%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
截至11月11日，Capricor Therapeutics的股價爲$19.54。在過去的52週中，股價上漲了508.72%。鑑於這些回報通常是積極的，長期股東在這份業績公佈前應該感到滿意。
To track all earnings releases for Capricor Therapeutics visit their earnings calendar on our site.
要追蹤Capricor Therapeutics的所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
